{"id":108154,"date":"2021-11-11T21:58:27","date_gmt":"2021-11-11T21:58:27","guid":{"rendered":"https:\/\/raed.academy\/?p=108154"},"modified":"2021-11-12T09:28:41","modified_gmt":"2021-11-12T09:28:41","slug":"molnupiravir-el-primer-farmac-eficac-contra-la-covid","status":"publish","type":"post","link":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/","title":{"rendered":"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid"},"content":{"rendered":"<p><a href=\"https:\/\/raed.academy\/ca\/academics\/dr-francisco-lopez-munoz\/\" target=\"_blank\" rel=\"noopener\"><strong><em>Francisco L\u00f3pez Mu\u00f1oz<\/em><\/strong><\/a><br \/>\n<em>Professor de Farmacologia, vicerector de Recerca i Ci\u00e8ncia i director de l&#8217;Escola Internacional de Doctorat de la Universitat Camilo Jos\u00e9 Cela i acad\u00e8mic de n\u00famero de la Reial Acad\u00e8mia Europea de Doctors-Barcelona 1914 (RAED)<\/em><\/p>\n<p><em>Article publicat al portal especialitzat The Conversation el 5 de novembre del 2021<\/em><\/p>\n<div id=\"attachment_46262\" style=\"width: 210px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-46262\" class=\"wp-image-46262\" src=\"https:\/\/raed.academy\/wp-content\/uploads\/2018\/06\/Francisco-L\u00f3pez-Mu\u00f1oz.jpg\" sizes=\"(max-width: 200px) 100vw, 200px\" srcset=\"https:\/\/raed.academy\/wp-content\/uploads\/2018\/06\/Francisco-L\u00f3pez-Mu\u00f1oz.jpg 290w, https:\/\/raed.academy\/wp-content\/uploads\/2018\/06\/Francisco-L\u00f3pez-Mu\u00f1oz-150x150.jpg 150w\" alt=\"Francisco L\u00f3pez Mu\u00f1oz\" width=\"200\" height=\"200\" aria-describedby=\"caption-attachment-46262\" \/><p id=\"caption-attachment-46262\" class=\"wp-caption-text\">Dr. Francisco L\u00f3pez<\/p><\/div>\n<p><a href=\"https:\/\/raed.academy\/ca\/academics\/dr-francisco-lopez-munoz\/\" target=\"_blank\" rel=\"noopener\"><strong><em>Francisco L\u00f3pez Mu\u00f1oz<\/em><\/strong><\/a>, professor de Farmacologia de la <strong>Universitat Camilo Jos\u00e9 Cela<\/strong> i acad\u00e8mic de n\u00famero de la <strong>Reial Acad\u00e8mia Europea de Doctors-Barcelona 1914<\/strong> (RAED), reflexiona sobre el primer f\u00e0rmac aprovat a la Uni\u00f3 Europea i el Regne Unit contra el coronavirus SARS CoV -2, causant de la Covid-19, a l&#8217;article <strong>&#8220;Ya disponemos del primer f\u00e1rmaco por v\u00eda oral contra la covid-19: el molnupiravir&#8221;<\/strong>, publicat al portal especialitzat <strong>The Conversation<\/strong> el passat 5 de novembre. L&#8217;acad\u00e8mic signa aquest article juntament amb <strong>Jos\u00e9 Antonio Guerra Guirao<\/strong>, professor de Farmacologia i Toxicologia de la Facultat de Farm\u00e0cia de la <strong>Universitat Complutense de Madrid<\/strong>.<\/p>\n<p>&#8220;Des de l&#8217;inici de la pand\u00e8mia de la Covid-19, les companyies farmac\u00e8utiques van comen\u00e7ar una cursa desesperada per obtenir un agent antiviral capa\u00e7 d&#8217;aturar la replicaci\u00f3 i transmissi\u00f3 del coronavirus SARS-CoV-2. A m\u00e9s, han estudiat diferents f\u00e0rmacs per al tractament simptomatol\u00f2gic de la malaltia amb resultats no gaire encoratjadors. Fins ara han estat assajats m\u00e9s de 400 principis actius per al tractament de la infecci\u00f3 per SARS-CoV-2. Entre els antivirals s&#8217;han aplicat el remdesivir i el baricitinib. A m\u00e9s se n&#8217;estan avaluant d&#8217;altres, com el favipiravir i el merimepodib. Tot i aix\u00f2, el 4 de novembre del 2021 les ag\u00e8ncies reguladores del Regne Unit (MHRA) i de la Uni\u00f3 Europea (EMA) informaven, amb una difer\u00e8ncia de diverses hores, de l&#8217;aprovaci\u00f3, mitjan\u00e7ant procediment d&#8217;emerg\u00e8ncia, d&#8217;un nou f\u00e0rmac antiviral d\u2019administraci\u00f3 oral per al tractament de la Covid-19. Es tracta del molnupiravir, de les companyies farmac\u00e8utiques <strong>Merck Sharp &amp; Dohme<\/strong> i <strong>Ridgeback Biotherapeutics<\/strong>&#8220;, introdueixen els autors l&#8217;article.<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-107987\" src=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp\" sizes=\"(max-width: 500px) 100vw, 500px\" srcset=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp 500w, https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst-440x264.webp 440w\" alt=\"molnupiravir\" width=\"500\" height=\"300\" \/>L\u00f3pez Mu\u00f1oz<\/strong> i <strong>Guerra Guirao<\/strong> expliquen que el molnupiravir \u00e9s un prof\u00e0rmac (un agent farmacol\u00f2gic que necessita activar-se dins del cos) que ha demostrat una activitat antiviral d&#8217;ampli espectre davant de diferents virus ARN no relacionats, inclosos el virus de la grip, el virus de l&#8217;ebola, el virus de l&#8217;encefalitis equina vene\u00e7olana i d&#8217;altres coronavirus. &#8220;El mecanisme d&#8217;acci\u00f3 consisteix a introduir errors de c\u00f2pia durant la replicaci\u00f3 de l&#8217;ARN viral, generant virus no viables. \u00c9s a dir, incapa\u00e7os d&#8217;infectar&#8221;, assenyalen.<\/p>\n<p>Els dos especialistes refereixen els assaigs cl\u00ednics en fase III que s&#8217;han portat a terme a 17 pa\u00efsos, entre els quals hi ha Espanya, en qu\u00e8 s&#8217;han incl\u00f2s m\u00e9s de 700 pacients amb Covid-19 confirmada mitjan\u00e7ant PCR que no requerien hospitalitzaci\u00f3. Els resultats obtinguts amb el molnupiravir posen de manifest una reducci\u00f3 del risc d&#8217;hospitalitzaci\u00f3 o de mort en aproximadament un 50% de pacients. &#8220;Aquestes dades tan esperan\u00e7adores han motivat que, tant als Estats Units com a Europa, es paralitzi l&#8217;assaig cl\u00ednic per poder aprovar el medicament mitjan\u00e7ant el procediment d&#8217;emerg\u00e8ncia&#8221;, destaquen <strong>L\u00f3pez Mu\u00f1oz<\/strong> i <strong>Guerra Guirao<\/strong>.<\/p>\n<h2><a href=\"https:\/\/theconversation.com\/ya-disponemos-del-primer-farmaco-por-via-oral-contra-la-covid-19-el-molnupiravir-171359\" target=\"_blank\" rel=\"noopener\">Llegiu l&#8217;article<\/a><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, a l&#8217;article &#8220;Ya disponemos del primer f\u00e1rmaco por v\u00eda oral contra la covid-19: el molnupiravir&#8221;<\/p>\n","protected":false},"author":12,"featured_media":107988,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[268,213,273],"tags":[],"class_list":["post-108154","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus-des-del-coneixement","category-medicina-i-cirurgia","category-salut","et-has-post-format-content","et_post_format-et-post-format-standard"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid - Reial Acad\u00e8mia Europea de Doctors<\/title>\n<meta name=\"description\" content=\"Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, el molnupiravir\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid - Reial Acad\u00e8mia Europea de Doctors\" \/>\n<meta property=\"og:description\" content=\"Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, el molnupiravir\" \/>\n<meta property=\"og:url\" content=\"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/\" \/>\n<meta property=\"og:site_name\" content=\"Reial Acad\u00e8mia Europea de Doctors\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/fb.me\/raed.academy\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-11T21:58:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-12T09:28:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"RAED\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@raedacademy\" \/>\n<meta name=\"twitter:site\" content=\"@raedacademy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RAED\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/\"},\"author\":{\"name\":\"RAED\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/person\\\/5a755da80d1d979fd66ba745c8702927\"},\"headline\":\"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid\",\"datePublished\":\"2021-11-11T21:58:27+00:00\",\"dateModified\":\"2021-11-12T09:28:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/\"},\"wordCount\":567,\"publisher\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/molnupiravir-dst.webp\",\"articleSection\":[\"Coronavirus des del coneixement\",\"Medicina i cirurgia\",\"Salut\"],\"inLanguage\":\"ca-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/\",\"name\":\"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid - Reial Acad\u00e8mia Europea de Doctors\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/molnupiravir-dst.webp\",\"datePublished\":\"2021-11-11T21:58:27+00:00\",\"dateModified\":\"2021-11-12T09:28:41+00:00\",\"description\":\"Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, el molnupiravir\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#breadcrumb\"},\"inLanguage\":\"ca-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#primaryimage\",\"url\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/molnupiravir-dst.webp\",\"contentUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/molnupiravir-dst.webp\",\"width\":500,\"height\":300,\"caption\":\"molnupiravir\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\",\"name\":\"Reial Acad\u00e8mia Europea de Doctors\",\"description\":\"Corporaci\u00f3n de derecho p\u00fablico de car\u00e1cter cient\u00edfico, t\u00e9cnico y art\u00edstico, que tiene por objeto la investigaci\u00f3n, el estudio, el fomento y la extensi\u00f3n del conocimiento en su sentido m\u00e1s amplio\",\"publisher\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/raed.academy\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\",\"name\":\"Real Academia Europea de Doctores\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/cropped-logo_raed.png\",\"contentUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/cropped-logo_raed.png\",\"width\":512,\"height\":512,\"caption\":\"Real Academia Europea de Doctores\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/fb.me\\\/raed.academy\",\"https:\\\/\\\/x.com\\\/raedacademy\",\"https:\\\/\\\/www.instagram.com\\\/raed.academy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCUYQwW2KrdirNWihxMDObwg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/person\\\/5a755da80d1d979fd66ba745c8702927\",\"name\":\"RAED\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"caption\":\"RAED\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid - Reial Acad\u00e8mia Europea de Doctors","description":"Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, el molnupiravir","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/","og_locale":"ca_ES","og_type":"article","og_title":"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid - Reial Acad\u00e8mia Europea de Doctors","og_description":"Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, el molnupiravir","og_url":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/","og_site_name":"Reial Acad\u00e8mia Europea de Doctors","article_publisher":"http:\/\/fb.me\/raed.academy","article_published_time":"2021-11-11T21:58:27+00:00","article_modified_time":"2021-11-12T09:28:41+00:00","og_image":[{"width":500,"height":300,"url":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp","type":"image\/webp"}],"author":"RAED","twitter_card":"summary_large_image","twitter_creator":"@raedacademy","twitter_site":"@raedacademy","twitter_misc":{"Written by":"RAED","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#article","isPartOf":{"@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/"},"author":{"name":"RAED","@id":"https:\/\/raed.academy\/ca\/#\/schema\/person\/5a755da80d1d979fd66ba745c8702927"},"headline":"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid","datePublished":"2021-11-11T21:58:27+00:00","dateModified":"2021-11-12T09:28:41+00:00","mainEntityOfPage":{"@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/"},"wordCount":567,"publisher":{"@id":"https:\/\/raed.academy\/ca\/#organization"},"image":{"@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp","articleSection":["Coronavirus des del coneixement","Medicina i cirurgia","Salut"],"inLanguage":"ca-ES"},{"@type":"WebPage","@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/","url":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/","name":"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid - Reial Acad\u00e8mia Europea de Doctors","isPartOf":{"@id":"https:\/\/raed.academy\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#primaryimage"},"image":{"@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp","datePublished":"2021-11-11T21:58:27+00:00","dateModified":"2021-11-12T09:28:41+00:00","description":"Francisco L\u00f3pez Mu\u00f1oz, sobre el primer f\u00e0rmac aprovat a la UE i el Regne Unit contra el SARS CoV-2, el molnupiravir","breadcrumb":{"@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#breadcrumb"},"inLanguage":"ca-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/"]}]},{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#primaryimage","url":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp","contentUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/11\/molnupiravir-dst.webp","width":500,"height":300,"caption":"molnupiravir"},{"@type":"BreadcrumbList","@id":"https:\/\/raed.academy\/ca\/molnupiravir-el-primer-farmac-eficac-contra-la-covid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/raed.academy\/ca\/"},{"@type":"ListItem","position":2,"name":"Molnupiravir, el primer f\u00e0rmac efica\u00e7 contra la Covid"}]},{"@type":"WebSite","@id":"https:\/\/raed.academy\/ca\/#website","url":"https:\/\/raed.academy\/ca\/","name":"Reial Acad\u00e8mia Europea de Doctors","description":"Corporaci\u00f3n de derecho p\u00fablico de car\u00e1cter cient\u00edfico, t\u00e9cnico y art\u00edstico, que tiene por objeto la investigaci\u00f3n, el estudio, el fomento y la extensi\u00f3n del conocimiento en su sentido m\u00e1s amplio","publisher":{"@id":"https:\/\/raed.academy\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/raed.academy\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca-ES"},{"@type":"Organization","@id":"https:\/\/raed.academy\/ca\/#organization","name":"Real Academia Europea de Doctores","url":"https:\/\/raed.academy\/ca\/","logo":{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/raed.academy\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/raed.academy\/wp-content\/uploads\/2017\/01\/cropped-logo_raed.png","contentUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2017\/01\/cropped-logo_raed.png","width":512,"height":512,"caption":"Real Academia Europea de Doctores"},"image":{"@id":"https:\/\/raed.academy\/ca\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/fb.me\/raed.academy","https:\/\/x.com\/raedacademy","https:\/\/www.instagram.com\/raed.academy\/","https:\/\/www.youtube.com\/channel\/UCUYQwW2KrdirNWihxMDObwg"]},{"@type":"Person","@id":"https:\/\/raed.academy\/ca\/#\/schema\/person\/5a755da80d1d979fd66ba745c8702927","name":"RAED","image":{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","caption":"RAED"}}]}},"_links":{"self":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts\/108154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/comments?post=108154"}],"version-history":[{"count":0,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts\/108154\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/media\/107988"}],"wp:attachment":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/media?parent=108154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/categories?post=108154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/tags?post=108154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}